Article | February 16, 2022

Enhancing Decentralized Clinical Trials Through Advanced Digital Platforms

By Edward Triebell, MRN

Clinical Trial Transparency: The Technology Imperative

For the past several years there has been an increasing shift in the clinical trial industry from studies conducted in hospital or clinic settings to decentralized clinical trials (DCTs) conducted in the patient’s home. The convenience and flexibility of DCTs have been shown to reduce or eliminate the need to travel to a specific site, boosting patient engagement and optimizing the trial experience. Retaining patients and keeping them actively engaged in a trial is a key issue in centralized studies, and MRN’s focus on in-home decentralized services addresses the problem by bringing a patient-centric approach to clinical trials


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader

MRN - Medical Research Network